Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Carcinogenesis

• Publication date

  1993-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/CARCIN/14.4.585PMID 8472319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro activation of the dioxin receptor to a DNA-binding form by food-borne heterocyclic amines.

  1992cited by this paper
• Cytochrome P450IA expression in adult and fetal human liver.

  1992cited by this paper
• Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl- 6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef.

  1992cited by this paper
• Identification of the epitope of a monoclonal antibody which binds to several cytochromes P450 in the CYP1A subfamily.

  1992cited by this paper
• Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens.

  1992cited by this paper
• Orientation of cytochromes P450 in the endoplasmic reticulum.

  1991cited by this paper
• Identification of a functionally conserved surface region of rat cytochromes P450IA.

  1991cited by this paper
• Expression of cytochrome P450IA in breast cancer.

  1991cited by this paper
• Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization

  1991cited by this paper
• Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes.

  1991cited by this paper
• The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature

  1991cited by this paper
• A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

  1991cited by this paper
• 32P Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent.

  1991cited by this paper
• Intralobular distribution and quantitation of cytochrome P‐450 enzymes in human liver as a function of age

  1991cited by this paper
• The 1990 Pharmaceutical Manufacturers Association of Canada keynote lecture. The role of the cytochromes P450 in the detoxication and activation of drugs and other chemicals.

  1991cited by this paper
• Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.

  1991cited by this paper
• Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in cigarette smoke condensate.

  1991cited by this paper
• A comparison of levels of glutathione transferases, cytochromes P450 and acetyltransferases in human livers.

  1991cited by this paper
• Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation.

  1991cited by this paper
• Activation of amino-alpha-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes.

  1991cited by this paper
• The expression of human cytochrome P450IA1 in the yeast Saccharomyces cerevisiae.

  1991cited by this paper
• Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1.

  1990cited by this paper
• Immunochemical and molecular biological studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities.

  1990cited by this paper
• Cloning and characterization of two major 3-methylcholanthrene inducible hamster liver cytochrome P450s.

  1990cited by this paper
• Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues.

  1990cited by this paper
• Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

  1990cited by this paper
• Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.

  1990cited by this paper
• Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.

  1990cited by this paper
• Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

  1990cited by this paper
• Monoclonal antibody-directed characterization of benzene, ethoxyresorufin and pentoxyresorufin metabolism in rat liver microsomes.

  1990cited by this paper
• Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas.

  1990cited by this paper
• An anti-peptide antibody targeted to a specific region of rat cytochrome P-450IA2 inhibits enzyme activity.

  1990cited by this paper
• Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes.

  1990cited by this paper
• Identification of cytochrome P450IA2 as a human autoantigen.

  1990cited by this paper
• Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002.

  1989cited by this paper
• Identification and location of alpha-helices in mammalian cytochromes P450.

  1989cited by this paper
• Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

  1989cited by this paper
• Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver.

  1989cited by this paper
• Activation of the food-derived mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450.

  1989cited by this paper
• Metabolic Activation of Pyrolysate Arylamines by Human Liver Microsomes; Possible Involvement of a P‐448‐H Type Cytochrome P‐450

  1988cited by this paper
• Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver.

  1988cited by this paper
• Antibodies to a synthetic peptide that react specifically with a common surface region on two hydrocarbon-inducible isoenzymes of cytochrome P-450 in the rat.

  1988cited by this paper
• Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.

  1988cited by this paper
• Identification and quantitation in human liver of cytochromes P-450 analogous to rabbit cytochromes P-450 forms 4 and 6.

  1988cited by this paper
• A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking.

  1988cited by this paper
• P-450 cytochromes: structure and function.

  1987cited by this paper
• High-resolution crystal structure of cytochrome P450cam.

  1987cited by this paper
• Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.

  1987cited by this paper
• Correlation of placental microsomal activities with protein detected by antibodies to rabbit cytochrome P-450 isozyme 6 in preparations from humans exposed to polychlorinated biphenyls, quaterphenyls, and dibenzofurans.

  1986cited by this paper
• Human cytochrome P-450 4 mRNA and gene: part of a multigene family that contains Alu sequences in its mRNA.

  1986cited by this paper
• An assay for paracetamol, produced by the O-deethylation of phenacetin in vitro, using gas chromatography/electron capture negative ion chemical ionization mass spectrometry.

  1986cited by this paper
• Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat.

  1986cited by this paper
• Human P3(450): cDNA and complete amino acid sequence.

  1986cited by this paper
• Complete amino acid sequence of a cytochrome P-450 isolated from beta-naphthoflavone-induced rabbit liver microsomes. Comparison with phenobarbital-induced and constitutive isozymes and identification of invariant residues.

  1986cited by this paper
• Complete nucleotide sequence of a methylcholanthrene-inducible cytochrome P-450 (P-450d) gene in the rat.

  1985cited by this paper
• A monoclonal antibody raised to rat liver cytochrome P-448 (form C) which recognises an epitope common to many other forms of cytochrome P-450.

  1985cited by this paper
• Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence.

  1985cited by this paper
• The structure of phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4. Production and characterization of site-specific antibodies.

  1985cited by this paper
• Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein.

  1985cited by this paper
• Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450.

  1985cited by this paper
• Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.

  1985cited by this paper
• Use of monoclonal antibody probes against rat hepatic cytochromes P-450c and P-450d to detect immunochemically related isozymes in liver microsomes from different species.

  1984cited by this paper
• The murine Ah locus. Comparison of the complete cytochrome P1-450 and P3-450 cDNA nucleotide and amino acid sequences.

  1984cited by this paper
• Antibodies of predetermined specificity in biology and medicine.

  1984cited by this paper
• Revised methods for the Salmonella mutagenicity test.

  1983cited by this paper
• Immunochemical relatedness of rat hepatic microsomal cytochromes P-450c and P-450d.

  1982cited by this paper
• Tapping the immunological repertoire to produce antibodies of predetermined specificity

  1982cited by this paper
• Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.

  1980cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates.

  1979cited by this paper
• Acetylornithinase of Escherichia coli: partial purification and some properties.

  1956cited by this paper

• Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes

  2020cites this paper
• Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice

  2019cites this paper
• Variable inhibitory effect of herbal supplements of different brands on human P450 CYP1A2

  2012cites this paper
• Species Differences of Drug‐Metabolizing Enzymes

  2011cites this paper
• The screening for single nucleotide polymorphisms of CYP3A4 in chronic myelogenous leukemia patients receiving imatinib

  2009cites this paper
• Role of human CYP1A1 and NAT2 in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutagenicity and DNA adducts

  2009cites this paper
• Identification of Human Liver Cytochrome P450 Isoforms Involved in Autoinduced Metabolism of the Antiangiogenic Agent (Z)-5-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic Acid (TSU-68)

  2008cites this paper
• Identification of human liver cytochrome P450 isoforms involved in autoinduced metabolism of the anti-angiogenic agent

  2008influential citation
• Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.

  2008cites this paper
• In vitro metabolism of indiplon and an assessment of its drug interaction potential

  2007cites this paper
• Mouse lung CYP 1 A 1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo [ 4 , 5b ] pyridine ( PhIP )

  2007cites this paper
• Enzymatic analysis of cDNA-expressed human CYP1A1, CYP1A2, and CYP1B1 with 7-ethoxyresorufin as substrate.

  2006cites this paper
• Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

  2006cites this paper
• Susceptibility to Exposure to Heterocyclic Amines from Cooked Food: Role of UDP‐Glucuronosyltransferases

  2006cites this paper
• Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.

  2005cites this paper
• Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers.

  2005cites this paper
• PASSCLAIM1—Diet-related cancer

  2004cites this paper
• Chicken Egg Yolk as an Excellent Source of Highly Specific Antibodies Against Cytochromes P450

  2004cites this paper
• DNA adduct formation by the anticancer drug ellipticine and its hydroxy derivatives in human breast adenocarcinoma MCF-7 cells

  2004cites this paper
• Constitutive and inducible expression of cytochromes P4501A (CYP1A1 and CYP1A2) in normal prostate and prostate cancer cells

  2004cites this paper
• Metabolic activation of 10-aza-substituted benzo[a]pyrene by cytochrome P450 1A2 in human liver microsomes.

  2004cites this paper
• Identification of epitopes on cytochrome P450 3A4/5 recognized by monoclonal antibodies.

  2003cites this paper
• DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling

  2003cites this paper
• In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes

  2003cites this paper
• Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver.

  2003cites this paper
• Cytochrome P450 in vitro reaction phenotyping: a re-evaluation of approaches used for P450 isoform identification.

  2003cites this paper
• CYTOCHROME P 450 IN VITRO REACTION PHENOTYPING : A RE-EVALUATION OF APPROACHES USED FOR P 450 ISOFORM IDENTIFICATION

  2003cites this paper
• Heterocyclic amines: evaluation of their role in diet associated human cancer.

  2003cites this paper
• IN VITRO EFFECT OF STANDARDIZED GINSENG EXTRACTS AND INDIVIDUAL GINSENOSIDES ON THE CATALYTIC ACTIVITY OF HUMAN CYP 1 A 1 , CYP 1 A 2 , AND CYP 1 B 1

  2002cites this paper
• 4-Hydroxylation of debrisoquine by human CYP1A1 and its inhibition by quinidine and quinine.

  2002cites this paper
• Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.

  2002cites this paper
• In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.

  2002cites this paper
• Assessment of P450 induction in the marmoset monkey using targeted anti-peptide antibodies.

  2001cites this paper
• Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.

  2001cites this paper
• Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine

  2001influential citation
• Immunohistochemical Detection of Carcinogen‐DNA Adducts in Normal Human Prostate Tissues Transplanted into the Subcutis of Athymic Nude Mice: Results with 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP) and 3,2′‐Dimethyl‐4‐aminobiphenyl (DMAB) and Relation to Cytochrome P450s and N‐Acetyltran

  2000cites this paper
• Identification of cytochrome P450 isoform involved in the metabolism of YM992, a novel selective serotonin re-uptake inhibitor, in human liver microsomes

  2000cites this paper
• Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.

  1999cites this paper
• Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide.

  1999cites this paper
• Drug Interactions with Tobacco Smoking

  1999cites this paper
• Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes.

  1999cites this paper
• Metabolic Activation of Dacarbazine by Human Cytochromes P 450 : The Role of CYP 1 A 1 , CYP 1 A 2 , and CYP 2 E 11

  1999cites this paper
• Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102.

  1999cites this paper
• Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin.

  1999cites this paper
• Development of a non-high pressure liquid chromatography assay to determine [14C]chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes.

  1998cites this paper
• Activation of heterocyclic amines by combinations of prostaglandin H synthase-1 and -2 with N-acetyltransferase 1 and 2.

  1998cites this paper
• Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans.

  1998cites this paper
• Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1.

  1998cites this paper
• Metabolism of 2-amino-1-methyl-6-phenylimidazo [ 4 , 5b ] pyridine by human cytochrome P 4501 A 1 , P 4501 A 2 and P 4501 B 1

  1998cites this paper
• A sensitive method for the simultaneous determination of caffeine and its dimethylxanthine metabolites in human plasma : Application to CYP1A2 phenotyping

  1998cites this paper
• Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo.

  1998cites this paper
• Detection of CYP1A1 protein in human liver and induction by TCDD in precision-cut liver slices incubated in dynamic organ culture.

  1998cites this paper
• Specific inhibition of human CYP1A2 using a targeted antibody.

  1997cites this paper
• Metabolic activation of toxins: tissue-specific expression and metabolism in target organs.

  1997cites this paper
• Assessing human risk to heterocyclic amines.

  1997cites this paper
• Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human cytochrome P4501B1.

  1997cites this paper
• Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes.

  1997cites this paper
• Induction of DNA damage by risk factors of colon cancer in human colon cells derived from biopsies.

  1997cites this paper
• Inducibility of cytochromes P-450 by dioxin in liver and extrahepatic tissues of the marmoset monkey (Callithrix jacchus).

  1996cites this paper
• Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta.

  1996cites this paper
• Idiosyncratic Drug Reactions

  1996cites this paper
• Localization Of Cytochromes P450 In Human Tissues: Implications for chemical toxicity

  1996cites this paper
• Contribution of human cytochrome P450 to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol metabolism, as predicted from heterologous expression in yeast.

  1996cites this paper
• Enzymic and interindividual differences in the human metabolism of heterocyclic amines.

  1996cites this paper
• Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

  1996cites this paper
• Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies.

  1996cites this paper
• Expression of human cytochrome P4501A1 (CYP1A1) in Saccharomyces cerevisiae inhibits cell division.

  1996cites this paper
• Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity.

  1995cites this paper
• Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.

  1995cites this paper
• Molecular modelling of members of the P4502A subfamily: application to studies of enzyme specificity.

  1995cites this paper
• Metabolic activation of heterocyclic aromatic amines catalyzed by human arylamine N-acetyltransferase isozymes (NAT1 and NAT2) expressed in Salmonella typhimurium.

  1995cites this paper
• Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6.

  1995cites this paper
• Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes.

  1995cites this paper
• The anticarcinogen 3,3'-diindolylmethane is an inhibitor of cytochrome P-450.

  1995cites this paper
• Regulation of the constitutive expression of the human CYP1A2 gene: cis elements and their interactions with proteins.

  1995cites this paper
• Exposure to and activation of dietary heterocyclic amines in humans.

  1995cites this paper
• Production of a form-specific, inhibitory antibody against rat cytochrome P450 2B1 using a synthetic peptide antigen against a putative substrate binding site.

  1995cites this paper
• Inhibition of in vitro aflatoxin B1-DNA binding in rainbow trout by CYP1A inhibitors: alpha-naphthoflavone, beta-naphthoflavone and trout CYP1A1 peptide antibody.

  1995cites this paper
• Determination of human hepatic cytochrome P4501A2 activity in vitro use of tacrine as an isoenzyme-specific probe.

  1995cites this paper
• Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450bm3).

  1995cites this paper
• Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research

  1995cites this paper
• Inhibition of in vitro aflatoxin B1-DNA binding in rainbow trout by CYP1A inhibitors: α-naphthoflavone, β-naphthoflavone and trout CYP1A1 peptide antibody

  1995cites this paper
• Assessment of the Use of Single Cytochrome P450 Enzymes in Drug Research

  1994cites this paper
• Development of a human lymphoblastoid cell line constitutively expressing human CYP1A1 cDNA: substrate specificity with model substrates and promutagens.

  1994cites this paper
• Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer.

  1994cites this paper
• Human Cells as an Expression System for Cytochromes P450

  1994cites this paper
• Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) by human liver microsomes.

  1994cites this paper
• Removal of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the male Fischer-344 rat.

  1994cites this paper
• Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.

  1994cites this paper
• Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver.

  1994cites this paper
• Genetic toxicology using human cell lines expressing human P-450.

  1993cites this paper
• Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.

  1993cites this paper